Table of Contents
<< Previous Issue | Jun 2011 (Vol: 2011, Issue: 6) | Next Issue >> |
- Section: Distribution & Marketing
-
Merck & Co. Joins Forces with Roche for Promotion of Victrelis™
- Section: Licensing
-
AVEO Licenses Early-Stage RON-Targeted Antibodies to Centocor Ortho Biotech
-
Vertex Enhances its HCV Pipeline by Licensing Alios BioPharma’s Nucleotide Analogues
-
Boehringer Ingelheim Licenses Zealand Pharma’s Drug Candidates for Type 2 Diabetes and Obesity
-
Abbott to Develop and Commercialise Biotest’s BT-061 for Autoimmune Diseases
-
Merck & Co. and Hanwha Chemical Partner to Develop a Biosimilar Version of Enbrel®
- Section: Mergers & Acquisitions
-
Shire to Enter Regenerative Medicine Market with Advanced BioHealing Acquisition
-
Valeant Continues its Expansion in Central and Eastern Europe with Sanitas Acquisition
-
Watson Increases its European Presence with US$563 M Specifar Acquisition
- Section: Research & Development
-
Heptares Therapeutics and AstraZeneca to Research GPCR Drug Targets